Net Cash Provided by (Used in) Financing Activities in USD of TuHURA Biosciences, Inc./NV from 2011 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
TuHURA Biosciences, Inc./NV quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2011 to Q1 2025.
  • TuHURA Biosciences, Inc./NV Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$548K, a 112% decline year-over-year.
  • TuHURA Biosciences, Inc./NV annual Net Cash Provided by (Used in) Financing Activities for 2024 was $29.8M, a 1019% increase from 2023.
  • TuHURA Biosciences, Inc./NV annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.66M, a 87.7% decline from 2022.
  • TuHURA Biosciences, Inc./NV annual Net Cash Provided by (Used in) Financing Activities for 2022 was $21.6M, a 16.9% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

TuHURA Biosciences, Inc./NV Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$548K -$5.18M -112% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 $4.63M 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q3 2023 -$2M -$3.91M -205% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q3 2022 $1.91M -$12M -86.3% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q3 2021 $13.9M -$9.48M -40.6% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q3 2020 $23.4M +$16.7M +253% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q3 2019 $6.61M +$8.7M 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q3 2018 -$2.09M -$11M -123% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q3 2017 $8.94M +$8.69M +3409% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q3 2016 $255K -$2.2M -89.6% 01 Jul 2016 30 Sep 2016 10-Q 10 Nov 2016
Q3 2015 $2.45M +$1.92M +365% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q3 2014 $528K 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q3 2012 $2.97M +$2.97M 01 Jul 2012 30 Sep 2012 10-Q/A 20 Dec 2012
Q2 2012 $0 $0 01 Apr 2012 30 Jun 2012 10-K/A 20 Dec 2012
Q3 2011 $0 01 Jul 2011 30 Sep 2011 10-Q/A 20 Dec 2012
Q2 2011 $0 01 Apr 2011 30 Jun 2011 10-K/A 20 Dec 2012

TuHURA Biosciences, Inc./NV Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $29.8M +$27.1M +1019% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $2.66M -$19M -87.7% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $21.6M -$4.41M -16.9% 01 Jul 2021 30 Jun 2022 10-K 18 Sep 2023
2021 $26M +$19.4M +295% 01 Jul 2020 30 Jun 2021 10-K 27 Sep 2022
2020 $6.6M +$2.53M +62% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021
2019 $4.07M -$5.18M -56% 01 Jul 2018 30 Jun 2019 10-K 18 Sep 2020
2018 $9.25M +$781K +9.22% 01 Jul 2017 30 Jun 2018 10-K 09 Sep 2019
2017 $8.47M -$1.1M -11.5% 01 Jul 2016 30 Jun 2017 8-K 03 Jun 2019
2016 $9.57M +$8.72M +1028% 01 Jul 2015 30 Jun 2016 10-K 13 Sep 2016
2015 $848K -$1.63M -65.8% 01 Jul 2014 30 Jun 2015 10-K 13 Sep 2016
2014 $2.48M 01 Jul 2013 30 Jun 2014 10-K 16 Nov 2015
2012 $7.48K +$7.48K 01 Jul 2011 30 Jun 2012 10-K/A 20 Dec 2012
2011 $0 01 Jul 2010 30 Jun 2011 10-K/A 20 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.